Investor Alert: Deadline Approaching for Class Action Lawsuit
Investors who have a stake in Kyverna Therapeutics, Inc. (KYTX) should take note of an important deadline approaching in a class action lawsuit against the company. The law firm Glancy Prongay & Murray LLP is reminding investors of this deadline.
The lawsuit involves allegations related to securities violations by Kyverna Therapeutics, Inc. Investors who purchased or otherwise acquired Kyverna securities between May 25, 2021, and October 1, 2021, may be eligible to participate in the class action lawsuit.
It is crucial for investors to be aware of their rights and options in this situation. The deadline to apply to be a lead plaintiff in the class action lawsuit is fast approaching, so investors should act promptly if they wish to participate.
If you believe you may be affected by this lawsuit, it is advisable to consult with legal counsel to understand your rights and take appropriate action. Stay informed about developments in this case and make sure to meet any deadlines if you decide to pursue legal recourse. Your financial interests are important, so it’s essential to stay informed and protect your rights as an investor.
